MedPath

Satiety of High-Protein Ramen Noodles

Not Applicable
Completed
Conditions
Appetitive Behavior
Interventions
Other: High protein ramen
Other: Standard ramen
Registration Number
NCT05725681
Lead Sponsor
Texas Tech University
Brief Summary

The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-protein instant ramen noodles reduces caloric intake at the next meal compared to standard instant ramen noodles.

Detailed Description

The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-protein instant ramen noodles reduces caloric intake at the next meal compared to standard instant ramen noodles. Subjects meeting the eligibility criteria will be recruited and offered a 2-condition, randomized, crossover postprandial study. Participants will be asked to limit physical activity to a specified level, consume a standardized meal at night and report to the clinic after a 12 h overnight fast. At our clinic, in random order, participants will consume: 1) one portion of high-protein instant ramen noodles (71 g; Chef Woo, Borealis Foods); 2) an isocaloric, weight matched portion of standard instant ramen noodles. The participants will have to finish consuming the noodles within 15 minutes. Water will be provided at the time of breakfast and for the next two hours. In the 4-hours following the ramen breakfast, blood will be sampled at regular intervals (0 minutes - before starting the breakfast, and 30, 60, 120 and 180 minutes after stopping breakfast) for hunger and satiety hormones (i.e., glucagon like peptide-1, peptide-YY, and ghrelin), and glucose and insulin. Visual Analogue Scales will also be administered to assess subjective hunger and satiety. At 4-hours, a buffet-style lunch will be provided and caloric intake at the meal will be covertly assessed. Subjects will leave the clinic at this point. The process will be repeated for the second condition after at least 7 d washout period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Body Mass Index 20-30 kg/m2
Exclusion Criteria
  • Unwilling or unable to have an IV catheter inserted

  • Body weight <110 pounds

  • Diabetes (any type)

  • Fasting capillary glucose ≥100 mg/dL

  • Unstable systemic medical condition

    •>10% change in body weight in the prior 3 months

  • Medications that affect appetite or glucose regulation

  • Prior bariatric surgery

  • Uncontrolled hypertension (i.e., unmedicated blood pressure >130/90 mmHg)

  • Intolerance, dislike or allergy to the study food

  • Current or recent (within 6 months) tobacco use

  • High alcohol consumption (>14 drinks/week)

  • Currently following a weight loss diet

  • Irregular menstrual cycle

  • Currently pregnant or lactating

  • Principal investigator discretion (e.g., disrespectful or inappropriate interactions with study staff

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
High protein ramenHigh protein ramen-
Standard ramenStandard ramen-
Primary Outcome Measures
NameTimeMethod
Appetite Score Area Under the Curve (mm*180 minutes)0 to 180 minutes

Calculated as satiety + fullness + (100 - hunger) + (100 - prospective food consumption)/4. Questions 1-4 from the Visual Analogue Scale will be used to assess satiety, fullness, hunger and prospective food consumption and calculate the Appetite Score

Secondary Outcome Measures
NameTimeMethod
Ghrelin Area Under the Curve (pg/mL*180 minutes)0 to 180 minutes

Measured in plasma

Perceived Hunger Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Perceived Satiety Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Perceived Fullness Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Peak Peptide-YY (PYY) (pg/mL)0 to 180 minutes

Measured in plasma

Desire to eat something fatty Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Energy intake at the buffet lunch (kcal)Served approximately 3.5 hours following the ramen meal test

Food consumed during the buffet lunch

Perceived hunger at peak GLP1 (mm)0 to 180 minutes

Assessed by visual analogue scale.

Perceived satiety at peak PYY (mm)0 to 180 minutes

Assessed by visual analogue scale.

Perceived fullness at peak PYY (mm)0 to 180 minutes

Assessed by visual analogue scale.

Prospective Food Consumption Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Peak Glucagon like peptide-1 (GLP-1) (pg/mL)0 to 180 minutes

Measured in plasma

Perceived satiety at peak GLP1 (mm)0 to 180 minutes

Assessed by visual analogue scale.

Perceived satiety at minimum ghrelin (mm)0 to 180 minutes

Assessed by visual analogue scale.

Perceived fullness at minimum ghrelin (mm)0 to 180 minutes

Assessed by visual analogue scale.

Glucagon like peptide-1 (GLP-1) Area Under the Curve (pg/mL*180 minutes)0 to 180 minutes

Measured in plasma

Peptide-YY (PYY) Area Under the Curve (pg/mL*180 minutes)0 to 180 minutes

Measured in plasma

Insulin Area Under the Curve (mUI*180 minutes)0 to 180 minutes

Measured in serum

Peak Insulin (mUI)0 to 180 minutes

Measured in serum

Perceived hunger at peak PYY (mm)0 to 180 minutes

Assessed by visual analogue scale.

Glucose Area Under the Curve (mg/dL*180 minutes)0 to 180 minutes

Measured in plasma

Minimum ghrelin (pg/mL)0 to 180 minutes

Measured in plasma

Perceived fullness at peak GLP1 (mm)0 to 180 minutes

Assessed by visual analogue scale.

Perceived hunger at minimum ghrelin (mm)0 to 180 minutes

Assessed by visual analogue scale.

Peak Glucose (mg/dL)0 to 180 minutes

Measured in plasma

Desire to eat something salty Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Desire to eat something savory Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Desire to eat something sweet Area Under the Curve (mm*180 minutes)0 to 180 minutes

Assessed by visual analogue scale.

Trial Locations

Locations (1)

Nutrition and Metabolic Health Initiative

🇺🇸

Lubbock, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath